ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics
HIT Consultant
OCTOBER 13, 2022
What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,
98 
Let's personalize your content